Nowadays, several NO-related therapies have been reported for the treatment and prevention of hypertension and/or kidney disease, such as supplementation of NO precursor arginine or citrulline, ADMA-lowering agents, NO donors, augmentation of activity of NOS, etc. [25]. The gene discussed is NOS2; the disease is hypertensive disorder.